FDA approves Artoss' NanoBone SBX Putty

Foley, Minn.-based biotech Artoss recently earned market clearance from the Food and Drug Administration for NanoBone SBX Putty.

NanoBone SBX Putty is a synthetic bone replacement material intended to stimulate quicker bone formation, according to the NanoBone's website.

Artoss plans to introduce the product to the U.S. market in the next few weeks.

More articles on supply chain:

5 trends on the growing role of digitization in supply chain
FDA approves expanded use of Janssen's Darzalex for multiple myeloma patients
Texas Blood Center in desperate need of O-negative blood



Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars